|
1
|
Gamliel Z: Incidence, epidemiology, and
etiology of esophageal cancer. Chest Surg Clin N Am. 10:441–450.
2000.PubMed/NCBI
|
|
2
|
Mehta NG and Mehta M: Overcoming
multidrug-resistance in cancer: statins offer a logical candidate.
Med Hypotheses. 74:237–239. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Katayama R, Koike S, Sato S, Sugimoto Y,
Tsuruo T and Fujita N: Dofequidar fumarate sensitizes cancer
stem-like side population cells to chemotherapeutic drugs by
inhibiting ABCG2/BCRP-mediated drug export. Cancer Sci.
100:2060–2068. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillet JP and Gottesman MM: Mechanisms of
multidrug resistance in cancer. Methods Mol Biol. 596:47–76. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fojo T and Coley HM: The role of efflux
pumps in drug-resistant metastatic breast cancer: new insights and
treatment strategies. Clin Breast Cancer. 7:749–756. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gottesman MM, Fojo T and Bates SE:
Multidrug resistance in cancer: role of ATP-dependent transporters.
Nat Rev Cancer. 2:48–58. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gottesman MM, Ambudkar SV and Xia D:
Structure of a multidrug transporter. Nat Biotechnol. 27:546–547.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mao Q and Unadkat JD: Role of the breast
cancer resistance protein (ABCG2) in drug transport. AAPS J.
7:E118–E133. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu HG, Pan YF, You J, Wang OC, Huang KT
and Zhang XH: Expression of ABCG2 and its significance in
colorectal cancer. Asian Pac J Cancer Prev. 11:845–848.
2010.PubMed/NCBI
|
|
10
|
Shanks GD: For severe malaria, artesunate
is the answer. Lancet. 376:1621–1622. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zoller T, Junghanss T, Kapaun A, Gjorup I,
Richter J, Hugo-Persson M, Mørch K, Foroutan B, Suttorp N, Yürek S
and Flick H: Intravenous artesunate for severe malaria in
travelers, Europe. Emerg Infect Dis. 17:771–777. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bello SO: Pre-referral artesunate in
severe malaria. Lancet. 373:1762–1763. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zeng Y, Ni X, Meng WT, Wen Q and Jia YQ:
Inhibitive effect of artesunate on human lymphoblastic
leukemia/lymphoma cells. Sichuan Da Xue Xue Bao Yi Xue Ban.
40:1038–1043. 2009.(In Chinese).
|
|
14
|
Steinbrück L, Pereira G and Efferth T:
Effects of artesunate on cytokinesis and G2/M cell cycle
progression of tumour cells and budding yeast. Cancer Genomics
Proteomics. 7:337–346. 2010.PubMed/NCBI
|
|
15
|
Hamacher-Brady A, Stein HA, Turschner S,
Toegel I, Mora R, Jennewein N, Efferth T, Eils R and Brady NR:
Artesunate activates mitochondrial apoptosis in breast cancer cells
via iron-catalyzed lysosomal reactive oxygen species production. J
Biol Chem. 286:6587–6601. 2011. View Article : Google Scholar
|
|
16
|
Michaelis M, Kleinschmidt MC, Barth S,
Rothweiler F, Geiler J, Breitling R, Mayer B, Deubzer H, Witt O,
Kreuter J, Doerr HW, Cinatl J and Cinatl J Jr: Anti-cancer effects
of artesunate in a panel of chemoresistant neuroblastoma cell
lines. Biochem Pharmacol. 79:130–136. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Efferth T, Giaisi M, Merling A, Krammer PH
and Li-Weber M: Artesunate induces ROS-mediated apoptosis in
doxorubicin-resistant T leukemia cells. PLoS One. 2:e6932007.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Reungpatthanaphong P and Mankhetkorn S:
Modulation of multidrug resistance by artemisinin, artesunate and
dihydroartemisinin in K562/adr and GLC4/adr resistant cell lines.
Biol Pharm Bull. 25:1555–1561. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Haufroid V: Genetic Polymorphisms of
ATP-binding cassette transporters ABCB1 and ABCC2 and their impact
on drug disposition. Curr Drug Targets. 12:631–646. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shukla S, Ohnuma S and Ambudkar SV:
Improving cancer chemotherapy with modulators of ABC drug
transporters. Curr Drug Targets. 12:621–630. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Doyle LA, Yang W, Abruzzo LV, Krogmann T,
Gao Y, Rishi AK and Ross DD: A multidrug resistance transporter
from human MCF-7 breast cancer cells. Proc Natl Acad Sci USA.
95:15665–15670. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li J, Li ZN, Du YJ, Li XQ, Bao QL and Chen
P: Expression of MRP1, BCRP, LRP, and ERCC1 in advanced
non-small-cell lung cancer: correlation with response to
chemotherapy and survival. Clin Lung Cancer. 10:414–421. 2009.
View Article : Google Scholar
|
|
23
|
Ni Z and Mao Q: ATP-binding cassette
efflux transporters in human placenta. Curr Pharm Biotechnol.
12:674–685. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Poller B, Wagenaar E, Tang SC and Schinkel
AH: Double-transduced MDCKII cells to study human P-glycoprotein
(ABCB1) and breast cancer resistance protein (ABCG2) interplay in
drug transport across the blood-brain barrier. Mol Pharm.
8:571–582. 2011. View Article : Google Scholar
|
